Consistent with those studies, the present study found that patients with mutations in the TBL1XR1 gene had significantly lower PFS rates than those without mutations, both in the population of patients with NHL and in the overall population of patients with lymphoma. Here, TBL1XR1 is linked to non-Hodgkin lymphoma.